Using heparin molecules to manage COVID‐2019 is a research paper published in Research and Practice in Thrombosis and Haemostasis (2020). On theSindex it has a DataRank of 0. It has been cited 79 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Center for Information Technology
Grant: HL 142604
Center for Information Technology
Grant: HL094463
Center for Information Technology
Grant: HL144970
Center for Information Technology
Grant: HL146226
NHLBI NIH HHS
Grant: R01 HL094463
NHLBI NIH HHS
Grant: R01 HL142604
NHLBI NIH HHS
Grant: R01 HL144970
NHLBI NIH HHS
Grant: R01 HL146226
National Institutes of Health
Grant: 5R01HL144970-02
Synthesis and Pharmacological Evaluation of Homogenous Ultra-Low Molecular Weight Heparins
National Institutes of Health
Grant: 5R01HL142604-02
Mechanisms of coagulation-dependent pathologies in sickle cell disease
National Institutes of Health
Grant: 1R01HL146226-01
Fibrinolysis Evaluation in A-TREAT (‘FEAT’ Study)
FWCI
1.69
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals